Global Hair Extension Market Report 2023-2030: Locks & Bonds, Klix Hair Inc., and Balmain Hair Group BV Among Top Players in the Booming Hair Extension Market
28 sept. 2023 06h48 HE
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Hair Extension Market Forecast to 2030 - Global Analysis by Product Type, Source, and Distribution Channel" report has been added to ...
$1.78+ Billion Worldwide Protein Shampoo Industry to 2031 - Increasing Prevalence of Hair and Scalp-Related Diseases is Expected to Propel Growth
13 déc. 2022 06h13 HE
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Protein Shampoo Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...
Keratin Market Size is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 6%: Straits Research
25 oct. 2022 15h45 HE
|
Straits Research
New York, United States, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Keratin is a biochemical that is used in developing and producing personal care products, specifically for nails, skin, and hair. The...
Worldwide Hair Care Products Industry to 2028 - Featuring Procter Gamble, Avon Products and Revlon Among Others
16 juin 2022 06h13 HE
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Hair Care Products Market, by Type, by Distribution Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report has been...
Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita
18 déc. 2018 08h00 HE
|
Palvella Therapeutics
Wayne, PA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for...
Palvella Therapeutics Announces FDA Fast Track Designation for PTX-022 for Treatment of Pachyonychia Congenita
12 nov. 2018 08h00 HE
|
Palvella Therapeutics
Wayne, PA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for...